openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) over potential Wrongdoing

03-05-2024 04:41 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares.

An investigation on behalf of current long term investors in Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares.

An investigation was announced for long-term investors in shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) concerning potential breaches of fiduciary duties by certain directors and officers of Integra LifeSciences Holdings Corporation.

Investors who are current long term investors in Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: IART stocks follows a lawsuit filed against Integra LifeSciences Holdings Corporation over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: IART stocks, concerns whether certain Integra LifeSciences Holdings Corporation directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges that the defendants failed to disclose to investors that Integra had failed to take sufficient measures to remediate the violations identified by the FDA in the 2018 Form 483, 2019 Warning Letter, and the 2021 Form 483, that as a result of those deficiencies, since March 2018, all products manufactured in the Boston Facility had the potential for higher-than-permitted levels of endotoxin and would need to be recalled, that the Company was not making progress towards obtaining its PMA indication for SurgiMend, in part, because the manufacturing site that would produce the PMA product, the Boston Facility, was in continued violation of the FDA standards that Integra failed to rectify years after the initial notice of the violations and as a result the facility had to be shutdown to correct those ongoing deficiencies, and that as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) over potential Wrongdoing here

News-ID: 3411031 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Integra

Dermal Regeneration Template Market | Integra LifeScience
The Dermal Regeneration Template market report presents the global Dermal Regeneration Template sales and revenue by companies, regions, type and application and forecast to 2027. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis. Dermal Regeneration Template Market competition landscape by sales volume, price (USD/Unit), revenue (Million USD), cost profit analysis
Oculoplastic Surgery Market: What are the Future Growth Opportunities? Top Playe …
This detailed market study covers oculoplastic surgery market growth potentials which can assist the stake holders to understand key trends and prospects in oculoplastic surgery market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The
Global Oculoplastic Surgery Market 2020 | B. Braun Melsungen AG, Blink Medical L …
The Global Oculoplastic Surgery Market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The study provides company profiling, product picture and specifications, sales, market share and contact information of key manufacturers of Global Oculoplastic Surgery Market.The Key manufactures involved in this market
Cervical Fusion Market Synopsis 2018 To 2023| Risen With DePuy Spine, DePuy Spin …
Market Scenario: The neck pain occurs due to degenerative changes in spinal discs in the cervical region of the spine. Discectomy is the most common surgical procedures for problems related to the cervical vertebral column. The surgical procedure involves the removal of the vertebral disc. The cervical spinal fusion also known as arthrodesis is a surgery to connect selected bones in the cervical vertebral column of the spine below the neck. Factors
Global Hydrocephalus Shunts Market 2017- Johnson & Johnson,Integra LifeSciences
The report entitled Global Hydrocephalus Shunts Market 2017 presents key insights into the global Hydrocephalus Shunts market along with the latest up-to-date industry details and forthcoming Hydrocephalus Shunts industry trends, which will assist the readers to focus on product specification and end users driving the overall market revenue and profitability. Report Keynotes: The main motive of the report on "Global Hydrocephalus Shunts Market 2017" is to study comprehensive details of the market
Integra, Inc Completes Interface with Medicine-On-Time
Carson City, NV—February 27, 2009 – Integra, Inc. and Medicine-On-Time have released an interface between Integra’s industry leading set of work flow and document management solutions, DocuTrack and DeliveryTrack, and Medicine-On-Time’s personal prescription system. DocuTrack allows users to streamline pharmacy work flow through the automation of all paper, fax and electronic processing. DeliveryTrack is a complete delivery management solution providing electronic signature capture, real-time proof of delivery, bar code scanning of